These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pharmacologic vitreolysis. Gandorfer A Dev Ophthalmol; 2007; 39():149-156. PubMed ID: 17245084 [TBL] [Abstract][Full Text] [Related]
7. [Progression of pharmacologic vitreolysis research]. Zhou H; Ye J Zhonghua Yan Ke Za Zhi; 2014 Mar; 50(3):225-9. PubMed ID: 24841819 [TBL] [Abstract][Full Text] [Related]
8. [Use of enzyme in vitreoretinal surgery]. Czajka M; Pecold K Klin Oczna; 2002; 104(1):59-62. PubMed ID: 12046313 [TBL] [Abstract][Full Text] [Related]
14. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes. Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432 [TBL] [Abstract][Full Text] [Related]
16. Enzymatic Vitrectomy and Pharmacologic Vitreodynamics. Shah AR; Trese MT Dev Ophthalmol; 2016; 55():357-64. PubMed ID: 26501959 [TBL] [Abstract][Full Text] [Related]
17. Pharmacologic vitreolysis with ocriplasmin: rationale for use and therapeutic potential in vitreo-retinal disorders. Khoshnevis M; Sebag J BioDrugs; 2015 Apr; 29(2):103-12. PubMed ID: 25812991 [TBL] [Abstract][Full Text] [Related]
18. Objective of pharmacologic vitreolysis. Gandorfer A Dev Ophthalmol; 2009; 44():1-6. PubMed ID: 19494646 [TBL] [Abstract][Full Text] [Related]